Authorized Generic News Today

The most common asthma inhaler for children was discontinued at the start of this year, forcing parents and pediatricians to scramble to switch to an alternative. But more than a month later, the situation has not improved, and families remain caught in the middle of a fight between a drug company and pharmacy benefit managers…

Due to the convoluted drug pricing and reimbursement system, the authorized generic asthma med Flovent won’t be as broadly covered by PBMs as the original brand was.

A new “authorized generic” version will be available in its place, but experts worry about access.

The discontinuation aligns with a change to Medicaid rebates that may have had the inhaler’s manufacturer selling the drug at a loss.

This week, Sens. Ossoff and Warnock focused on maternal health research; uninsured patients affording insulin; specialty crop farmers; expanded health care for service members; water projects along the Chattahoochee River; and national security.   

FDA has posted an Addendum to Briefing Document on its website that was circulated to members of the AdCom ... | May 9, 2023

/PRNewswire/ -- Prasco Laboratories announced today the launch of the Authorized Generic of ZIOPTAN® (tafluprost ophthalmic solution) 0.0015%. This is Prascos...

Cumberland Pharmaceuticals Reports 9% Revenue Growth In 2020 News provided by Share this article NASHVILLE, Tenn., March 9, 2021 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology and rheumatology, today announced fourth quarter and full year 2020 financial results. Net Revenues for the fourth quarter were $10.3 million, up 10% over the prior year period. For the full year 2020, Net Revenues total...